Embolism and thrombosis of saphenous vein (greater) (lesser) ICD-10-CM Alphabetical Index References for 'I82.81 - Embolism and thrombosis of superficial veins of lower extremities' The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code I82.81. Click on any term below to browse the alphabetical index.
I82.813 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Embolism and thombos of superfic veins of low extrm, bi The 2022 edition of ICD-10-CM I82.813 became effective on October 1, 2021.
Acute embolism and thrombosis of left femoral vein. I82.412 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM I82.412 became effective on October 1, 2018.
Short description: Embolism and thrombosis of superficial veins of l low extrem The 2022 edition of ICD-10-CM I82.812 became effective on October 1, 2021. This is the American ICD-10-CM version of I82.812 - other international versions of ICD-10 I82.812 may differ.
Objective: Acute superficial vein thrombosis (SVT) of the axial veins, such as the great saphenous vein (GSV), is a common clinical condition that carries with it significant risk of propagation of thrombus, recurrence, and, most concerning, subsequent venous thromboembolism (VTE).
Great Saphenous Vein (GSV) – The GSV is the large superficial vein of the leg and the longest vein in the entire body. It can be found along the length of the lower limb, returning blood from the thigh, calf, and foot to the deep femoral vein at the femoral triangle. The femoral triangle is located in the upper thigh.
Abstract. Background: Isolated great saphenous vein thrombus (GSVT) is generally regarded as benign, and treatment is heterogeneous. Complications include thrombus propagation, new saphenous vein thrombosis, deep vein thrombosis (DVT), pulmonary embolism (PE), and symptom persistence.
ICD-10 Code for Acute embolism and thrombosis of unspecified deep veins of left lower extremity- I82. 402- Codify by AAPC.
The saphenous vein (otherwise known as the great saphenous vein or GSV) is the longest in the human body. It extends from the top of the foot to the upper thigh/groin area and like all veins, problems can occur.
SVT in the superficial axial veins (great saphenous vein or small saphenous vein) is generally considered to warrant aggressive treatment with low molecular weight heparin to prevent extension into the deep venous system, particularly if the SVT is close to the junction with the common femoral or popliteal veins.
The great saphenous vein (GSV, alternately "long saphenous vein"; /səˈfiːnəs/) is a large, subcutaneous, superficial vein of the leg. It is the longest vein in the body, running along the length of the lower limb, returning blood from the foot, leg and thigh to the deep femoral vein at the femoral triangle.
Thrombosis is a general term that refers to a partially or totally obstructed blood vessel, be it in a vein or an artery. When the problem occurs in a vein, it is generally referred to as thrombophlebitis.
Superficial vein thrombosis (SVT) refers to a blood clot in a vein near the surface, deep vein thrombosis (DVT) is a clot in a deep vein in the body, usually in the leg. Superficial vein thrombosis can present as pain and inflammation while deep clots can travel to the lungs and cause a pulmonary embolism.
ICD-10 code R22. 42 for Localized swelling, mass and lump, left lower limb is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
403: Acute embolism and thrombosis of unspecified deep veins of lower extremity, bilateral.
Acute DVT of unspecified vein of unspecified leg ICD 10 code is I81. 409.
The deep veins of the upper extremity include the paired ulnar, radial, and interosseous veins in the forearm; paired brachial veins of the upper arm; and axillary vein. The axillary vein originates at the lower border of the teres major muscle in continuity with the brachial veins.
In the proximal anterior thigh 3–4 centimetres (1.2–1.6 in) inferolateral to the pubic tubercle, the great saphenous vein dives down deep through the cribriform fascia of the saphenous opening to join the femoral vein.
The deep venous system of the calf includes the anterior tibial, posterior tibial, and peroneal veins. In the calf, these deep veins present as pairs on both sides of the artery.
While superficial veins lie just below the skin's surface collecting blood from the upper layers of tissue, deep veins are located underneath muscle tissue in the legs.
Embolism and thrombosis of superficial veins of lower extremities 1 I00-I99#N#2021 ICD-10-CM Range I00-I99#N#Diseases of the circulatory system#N#Type 2 Excludes#N#certain conditions originating in the perinatal period ( P04 - P96)#N#certain infectious and parasitic diseases ( A00-B99)#N#complications of pregnancy, childbirth and the puerperium ( O00-O9A)#N#congenital malformations, deformations, and chromosomal abnormalities ( Q00-Q99)#N#endocrine, nutritional and metabolic diseases ( E00 - E88)#N#injury, poisoning and certain other consequences of external causes ( S00-T88)#N#neoplasms ( C00-D49)#N#symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified ( R00 - R94)#N#systemic connective tissue disorders ( M30-M36)#N#transient cerebral ischemic attacks and related syndromes ( G45.-)#N#Diseases of the circulatory system 2 I82#N#ICD-10-CM Diagnosis Code I82#N#Other venous embolism and thrombosis#N#2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code#N#Code First#N#venous embolism and thrombosis complicating:#N#abortion, ectopic or molar pregnancy ( O00 - O07, O08.7)#N#pregnancy, childbirth and the puerperium ( O22.-, O87.-)#N#Type 2 Excludes#N#venous embolism and thrombosis (of):#N#cerebral ( I63.6, I67.6)#N#coronary ( I21 - I25)#N#intracranial and intraspinal, septic or NOS ( G08)#N#intracranial, nonpyogenic ( I67.6)#N#intraspinal, nonpyogenic ( G95.1)#N#mesenteric ( K55.0-)#N#portal ( I81)#N#pulmonary ( I26.-)#N#Other venous embolism and thrombosis 3 I82.8#N#ICD-10-CM Diagnosis Code I82.8#N#Embolism and thrombosis of other specified veins#N#2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code#N#Use Additional#N#code, if applicable, for associated long-term (current) use of anticoagulants ( Z79.01)#N#Embolism and thrombosis of other specified veins
The 2022 edition of ICD-10-CM I82.81 became effective on October 1, 2021.
I82.81 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
The ICD code I828 is used to code Paget-Schroetter disease. Paget–Schroetter disease, also known as Paget–von Schrötter disease, is a form of upper extremity deep vein thrombosis (DVT), a medical condition in which blood clots form in the deep veins of the arms.
I82.81. Non-Billable means the code is not sufficient justification for admission to an acute care hospital when used a principal diagnosis. Use a child code to capture more detail. ICD Code I82.81 is a non-billable code.
First, are the risk factors that are common for any venous thrombosis. Examples include thrombophilia, malignancy, age, immobility etc. There is evidence to suggest these factors are not rarely present in patients with saphenous vein thrombosis. A second group of risk factors are unique to saphenous vein thrombosis. Examples include post-ligation or post-EVLT. This is known as EHIT. Venous insufficiency is a risk factor for superficial vein thrombosis. However, when the thrombosis occurs outside of the varicose vein or in a vein in which there is no stagnant blood flow, other causes should be though of.
These include predominantly NSAIDs, graded compression stockings and warm compresses. It is important to note that these measures provide symptomatic relief, however do not reduce the risk of propagation of the clot. Surgical ligation is reserved for patients with frequent recurrences or for cosmetic reasons. When the choice is made not to anticoagulate close surveillance is usually recommended by serial duplex ultrasound examinations.
To date there is no clear recommendation as to the treatment of saphenous vein thrombosis. The latest ACCP guidelines suggests 45 days of prophylactic dose fondaparinux for ‘extensive’ lower extremity thrombosis. They are relying on the CALISTO study. One should note that the CALISTO investigators excluded many patients otherwise common in clinical practice such as patients with renal failure, malignancy, proven hypercoagulability and those with prior venous thromboembolism. Adequately, the level of this recommendation is quite weak. A 2012 mini-review published in the Annals of Internal Medicine echoed this finding pointing out that fondaparinux has to be given to 88 patients with saphenous vein thrombosis to prevent one deep vein thrombosis. A cheaper alternative may be low molecular weight heparin. However current data is confusing. The most problematic piece of information regarding low molecular weight heparin and saphenous vein thrombosis is that the deep vein thrombosis reducing effect may not be long-lived, as opposed to fondaparinux. On the other hand shorter duration of treatment was given. This data was again summarized without much change in a 2012 Cochrane database review of the matter.
As a side note, superficial vein thrombosis may be used to describe thrombosis in superficial veins in non-limb locations such as the abdominal wall. It is important not to dismiss these clots. While they appear to be superficial at first glance, these clots may actually represent extension from a deep vein thrombosis such as the inferior vena cava or a sign of Trousseau Syndrome.
There is no evidence to prove this approach is right. Proponents state that as the rate of clot progression is unpredictable, this approach is safe.
Modern data suggests that saphenous vein thrombosis can propagate. Furthermore, there is data to suggest that saphenous vein thrombosis actually commonly co-presents with deep vein thrombosis or even pulmonary embolism. These are most likely not rare occurrences and have been described as prevalent as 53%.
Historically saphenous vein thrombosis was regarded as a benign condition. It was a disease treated by surgeons and encountered mainly in immobilized post-surgical patients. However there is data to suggest otherwise. Modern data suggests that saphenous vein thrombosis can propagate.